DNAJB8 is well established as an effective immunotherapy target in cancer stem cells (CSCs) and cancer-initiating cells (CICs) due to its identified functions in the maintenance of CSCs and CICs of renal cell carcinoma [31]. The gene discussed is DNAJB8; the disease is cancer.